Business Context and Reporting Period
This Form 8-K is a current report filed by Spherix Incorporated (not Dominari Holdings Inc.) on November 16, 2009. The filing discloses the entry into a material definitive agreement regarding a registered direct offering of common stock and warrants.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $6.3 million.
- Net Proceeds: Expected to be approximately $6 million after deducting placement agent fees and estimated offering expenses.
- Securities Issued: 2,760,870 shares of common stock and warrants to purchase up to 1,104,348 additional shares.
- Offering Structure: Units consisting of one share of common stock and a warrant to purchase 0.40 of a share.
- Purchase Price: $2.30 per unit.
- Warrant Terms: Exercise price of $3.25 per share; exercisable from the issue date until November 16, 2014.
- Placement Agent Fees: 6% of gross proceeds plus warrants equal to 3% of shares sold and expense reimbursement up to $30,000.
Material Changes
The filing reports a significant capital raise event. The company entered into a securities purchase agreement with certain investors and a placement agent agreement with Rodman & Renshaw, LLC. This transaction represents a dilution of existing shareholders through the issuance of new common stock and warrants, intended to provide immediate liquidity to the company.
Outlook, Risks, and Management Commentary
- Closing Date: The offering is expected to close on or about November 19, 2009.
- Regulatory Status: The securities are issued pursuant to a prospectus supplement filed under an effective shelf registration statement (Form S-3, File No. 333-16153).
- Warrant Adjustments: The warrant exercise price is subject to adjustment for stock splits, dividends, or recapitalization transactions.
- Legal Opinion: An opinion regarding the legality of the issuance was provided by Baxter, Baker, Sidle, Conn & Jones, P.A.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected November 19, 2009) and confirm receipt of net proceeds.
- Review the full text of the Securities Purchase Agreement (Exhibit 1.1) for specific investor rights and covenants.
- Confirm the impact of the 2,760,870 new shares and potential 1,104,348 warrant shares on total outstanding share count and earnings per share.
- Check subsequent filings for any changes to the warrant exercise price or expiration terms.